Research News

Plymouth researchers are thanking local patients who have taken part in a clinical trial of the antiviral drug remdesivir in the treatment of coronavirus. Remdesivir was recently approved by the NHS to treat COVID-19: the first drug to be licensed for this use in the UK .

A joint study between the University of Plymouth and University Hospitals Plymouth NHS Trust (UHP) is analysing the differing immune responses of COVID-19 patients and working to develop a simple test that could help predict who is likely to develop serious illness.